Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · Schizophrenia

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 100%High 0 · 0%

Adverse effects: 3. Metabolic ‐ weight significant gain · schizophrenia

QUETIAPINE probably leads to lower adverse effects: 3. Metabolic ‐ weight significant gain compared with OLANZAPINE (moderate certainty).

1 finding from 1 review

Quetiapine versus other atypical antipsychotics for schizophrenia 2013 · Cochrane Headline outcomes only
RR 0.69 [0.51, 0.95]
7 studies · 1321 participants
Moderate